Dynavax Technologies
DVAX
#4990
Rank
A$2.58 B
Marketcap
A$22.03
Share price
0.00%
Change (1 day)
2.64%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -A$58.75 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$53.5 Million, an increase over its 2023 earnings that were of A$3.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.75 Million-209.79%
2024 A$53.5 M1475.31%
2023 A$3.39 M-99.2%
2022 A$0.42 B238.78%
2021 A$0.12 B-257.89%
2020 -A$79.85 Million-58.58%
2019 -A$0.2 Billion-9.32%
2018 -A$0.22 Billion60.44%
2017 -A$0.14 Billion-15.8%
2016 -A$0.16 Billion4.22%
2015 -A$0.16 Billion16.54%
2014 -A$0.13 Billion37.09%
2013 -A$94.5 Million
2010 -A$67.64 Million214.85%
2009 -A$21.49 Million-37.33%
2008 -A$34.28 Million-66.07%
2007 -A$0.11 Billion16.92%
2006 -A$86.42 Million170.36%
2005 -A$31.97 Million33.39%
2004 -A$23.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.05 B-31,352.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.91 B-26,914.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.30 B-4,889.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.92 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.69 B-38,910.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.84 B-43,371.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.22 B-29,642.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
A$29.36 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.22 B-6,801.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel